Table 2. IC50 and combination index values in AML cell lines.
Treatment | Kasumi-1 | MOLM13 | OCI-AML2 | OCI-AML3 |
Fasudil (IC50) | 37.8μM | 53.1μM | 47.9μM | 52.2μM |
Sapanisertib (IC50) | 2.1μM | 1.3μM | 0.4μM | 0.6μM |
Trametinib (IC50) | 3.8nM | 8.5nM | 19.7nM | 14.2nM |
F-50μM + S-0.5μM (Combination index) | 0.65 | 0.81 | 0.71 | 0.68 |
T-10nM + S-0.5μM (Combination index) | 0.86 | 0.93 | 1.06 | 1.03 |
T-10nM + F-50μM (Combination index) | 0.48 | 0.34 | 0.27 | 0.22 |